Category: Cardiopulmonary Resuscitation/Emergency Cardiac Care/Shock Background: Despite favorable metabolic effects of anti-diabetic thiazolidinedione drugs (TZDs), it is uncertain if TZDs reduce cardiovascular mortality. We previously showed that TZDs exert an off-target effect to block cardiac ATP-sensitive potassium (KATP) channels and may increase propensity for ischemic ventricular fibrillation (VF) in pigs. In this study, we tested the hypothesis that a TZD drug, rosiglitazone (ROSI), alters spectral characteristics of ischemic VF through effects on KATP channels.
